1. A Real‐World Multicentre Retrospective Study of Paclitaxel‐Bevacizumab and Maintenance Therapy as First‐Line for HER2‐Negative Metastatic Breast Cancer. Issue 6 (30th November 2016) Authors: Gamucci, Teresa; Mentuccia, Lucia; Natoli, Clara; Sperduti, Isabella; Cassano, Alessandra; Michelotti, Andrea; Di Lauro, Luigi; Sergi, Domenico; Fabi, Alessandra; Sarobba, Maria G.; Marchetti, Paolo; Barba, Maddalena; Magnolfi, Emanuela; Maugeri‐Saccà, Marcello; Rossi, Ernesto; Sini, Valentina; G... Journal: Journal of cellular physiology Issue: Volume 232:Issue 6(2017:Jun.) Page Start: 1571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bevacizumab as First-Line Treatment in HER2-Negative Advanced Breast Cancer: Pros and Cons. Issue 5 (September 2016) Authors: Sini, Valentina; Cassano, Alessandra; Corsi, Domenico; De Laurentiis, Michele; Gamucci, Teresa; Mauri, Mariella; Naso, Giuseppe; Roselli, Mario; Maria Ruggeri, Enzo; Tonini, Giuseppe; Vici, Patrizia; Zampa, Germano; Marchetti, Paolo Journal: Tumori Issue: Volume 102:Issue 5(2016) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab. Issue 4 (3rd April 2018) Authors: Pizzuti, Laura; Sergi, Domenico; Sperduti, Isabella; Lauro, Luigi Di; Mazzotta, Marco; Botti, Claudio; Izzo, Fiorentino; Marchetti, Luca; Tomao, Silverio; Marchetti, Paolo; Natoli, Clara; Grassadonia, Antonino; Gamucci, Teresa; Mentuccia, Lucia; Magnolfi, Emanuela; Vaccaro, Angela; Cassano, Aless... Journal: Cancer biology & therapy Issue: Volume 19:Issue 4(2018) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting. Issue 7 (7th August 2019) Authors: Pizzuti, Laura; Krasniqi, Eriseld; Barchiesi, Giacomo; Della Giulia, Marina; Izzo, Fiorentino; Sanguineti, Giuseppe; Marchetti, Paolo; Mazzotta, Marco; Giusti, Raffaele; Botticelli, Andrea; Gamucci, Teresa; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Iezzi, Laura; Tomao, Silverio; Tomao... Journal: International journal of cancer Issue: Volume 146:Issue 7(2020) Page Start: 1917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice. (April 2016) Authors: Sini, Valentina; Cinieri, Saverio; Conte, Pierfranco; De Laurentiis, Michelino; Leo, Angelo Di; Tondini, Carlo; Marchetti, Paolo Journal: Critical reviews in oncology/hematology Issue: Volume 100(2016) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice. (April 2016) Authors: Sini, Valentina; Cinieri, Saverio; Conte, Pierfranco; De Laurentiis, Michelino; Leo, Angelo Di; Tondini, Carlo; Marchetti, Paolo Journal: Critical reviews in oncology/hematology Issue: Volume 100(2016) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Over 17-month complete clinical brain response with a well-tolerated lapatinib plus capecitabine combination in a very young patient afflicted by HER2-positive metastatic breast cancer. Issue 6 (November 2013) Authors: Sini, Valentina; Menghi, Antonello; Cursano, Maria Concetta; Mandolini, Pier Luca; Lanza, Rosina Journal: Tumori Issue: Volume 99:Issue 6(2013) Page Start: e273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience. Issue 6 (10th December 2018) Authors: Pizzuti, Laura; Giordano, Antonio; Michelotti, Andrea; Mazzotta, Marco; Natoli, Clara; Gamucci, Teresa; De Angelis, Claudia; Landucci, Elisabetta; Diodati, Lucrezia; Iezzi, Laura; Mentuccia, Lucia; Fabbri, Agnese; Barba, Maddalena; Sanguineti, Giuseppe; Marchetti, Paolo; Tomao, Silverio; Mariani,... Journal: Journal of cellular physiology Issue: Volume 234:Issue 6(2019:Jun.) Page Start: 7708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting. (November 2021) Authors: Pizzuti, Laura; Krasniqi, Eriseld; Sperduti, Isabella; Barba, Maddalena; Gamucci, Teresa; Mauri, Maria; Veltri, Enzo Maria; Meattini, Icro; Berardi, Rossana; Di Lisa, Francesca Sofia; Natoli, Clara; Pistelli, Mirco; Iezzi, Laura; Risi, Emanuela; D'Ostilio, Nicola; Tomao, Silverio; Ficorella, Corr... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study. (22nd June 2015) Authors: Lambertini, Matteo; Ferreira, Arlindo R.; Poggio, Francesca; Puglisi, Fabio; Bernardo, Antonio; Montemurro, Filippo; Poletto, Elena; Pozzi, Emma; Rossi, Valentina; Risi, Emanuela; Lai, Antonella; Zanardi, Elisa; Sini, Valentina; Ziliani, Serena; Minuti, Gabriele; Mura, Silvia; Grasso, Donatella; ... Journal: Oncologist Issue: Volume 20:Number 8(2015) Page Start: 880 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗